Score history

NuScience Peptides score history

Every recorded change to NuScience Peptides’s overall score since October 14, 2026, with the audit note written at the time. Scores follow our published methodology; affiliate status never affects them.

Score today
6.43/10

Score today

Score changes
10

Score changes

Audit entries
11

Audit entries

Score over time

6.06.57.07.5Nov 20266.43
Overall score, October 18, 2026 to November 6, 2026. Each dot is a recorded score; the filled dot is today’s.

Every entry newest first

  1. Lowered from6.49to6.43(-0.06)

    Lab evidence re-checked on 2 November 2026. The melanotan II certificate (Freedom Diagnostics, reported 1 November 2025) passed 12 months old and is still the newest one the company posts for that product, so under the published age rule (A6) it now counts as an older certificate, alongside those for 5-amino-1MQ, IGF-1 LR3 and cagrilintide. The certificate itself was re-confirmed at the laboratory. Lab evidence 7.3 to 7.2.

  2. Raised from6.47to6.49(+0.02)

    Pricing recomputed on 26 October 2026: a vendor was removed from the directory, which moved the market median for the same products: pricing 7.7 to 7.8.

  3. Lowered from6.49to6.47(-0.02)

    Pricing recomputed on 24 October 2026 after Bionova Peptides' first-review prices were recorded; other vendors move only through the market medians: pricing 7.8 to 7.7.

  4. Raised from6.48to6.49(+0.01)

    Operating history re-checked on 22 October 2026 under the published rule (earliest dated evidence of the business, including a never-parked store domain and the named operating company, looked up for every vendor): operating history 4.3 to 4.5.

  5. Lowered from6.78to6.48(-0.30)

    Re-scored on 22 October 2026 under the published rulebook, which now gives one rule for each judgement call and applies it to every vendor: shipping and refunds 6.5 to 5.0.

  6. Raised from6.67to6.78(+0.11)

    Re-scored on 22 October 2026 under version 2 of our published rules. The deduction for verification codes the laboratory could not find was retired: each such certificate now keeps its points for the printed key and earns none for confirmation, and codes on certificates we do not score no longer count. Lab 7.1 to 7.3. Score 6.67 to 6.78.

  7. Raised from6.49to6.67(+0.18)

    Re-scored on 22 October 2026 under our published rubric for shipping, pricing, operating history and transparency, applied to every vendor the same day: prices re-read from the vendor's site and matched by milligrams per vial, operating history from the earliest dated evidence of the business, and policies scored item by item. shipping and refunds 5.5 to 6.5, pricing 7.7 to 7.8, operating history 4.0 to 4.3, transparency 2.5 to 1.5.

  8. Lowered from6.65to6.49(-0.16)

    Lab score recalculated on 22 October 2026 under the uniform published rubric applied to every vendor: every listed product was rescored on the same fixed certificate points, with fixed deductions for certificates more than 12 months old, one lot number printed on certificates for different compounds, site statements about testing that the certificates do not bear out and verification codes the issuing laboratory could not find. Lab 7.4 to 7.1.

  9. Raised from6.54to6.65(+0.11)

    Lab evidence re-checked on 20 October 2026 under our coverage rule, which counts a listed product with no published certificate as zero in the lab average. Certificates cover 17 of the 17 products we list that the vendor offers for sale. Lab 7.2 to 7.4.

  10. Lowered from7.13to6.54(-0.59)

    Re-audited 2026-10-18 from the live site. Lab 7.12 to 7.2: 36 Freedom Diagnostics and Chromate reports confirmed at the laboratories, with 34 posted files identical to the laboratory copies, offset by two image-only certificates that could not be matched, a 2024 cagrilintide report and limited endotoxin coverage; this replaces the May 2026 statement that the vendor published no certificates. Shipping 8.5 to 5.5: all sales are final and the terms disclaim responsibility for lost or damaged parcels when insurance is declined. Pricing 8.5 to 7.7: standard list prices measured at about 1.12 times the market median, and every product is shown at a markdown from a higher struck-through list price; a small deduction because the markdown is permanent. Tenure 3.3 to 4.0: the domain was registered in May 2023 and the earliest posted certificate is from July 2024. Transparency 1.5 to 2.5: phone, email, city and a public certificate library are given, but no operating company or street address appears on the site, and the FDA issued a warning letter on 24 August 2026. The products named in that letter have been removed from the catalog. Note added 22 October 2026: the deduction for a permanent markdown was withdrawn on 22 October 2026; a standing sale price now counts as the price.

  11. Re-checked, no change

    Added the FDA warning letter of 24 August 2026 (reference 733652), replacing an outdated statement that no letter had been identified.

Score changes for every vendor are on the score changes page. NuScience Peptides may display its current score with the score badge, which updates automatically and has no effect on the score.

Age verification

Are you 18 or older?

Peptide Source Review covers research peptides: substances sold for laboratory and research purposes, not for human consumption. By continuing, you confirm that you are at least 18 years old and that nothing on this site is medical or legal advice.

I am not 18, leave

We use a one-time browser memory (localStorage) so you don’t see this again on this device.